Literature DB >> 19450895

Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.

Shijun Kang1, Jianmin Xie, Shudong Ma, Wangjun Liao, Junyi Zhang, Rongcheng Luo.   

Abstract

Chemokines secreted by DC are instrumental for DC to regulate their own migratory capacities and to recruit T lymphocytes during local tumour immune response. Using the recently developed chemokine protein arrays, we analyzed 38 chemokines associated with monocyte-derived DC (MoDC), including the CC family (CCL2, CCL3, CCL4, CCL17, CCL18, CCL22, CCL23, CCL24, CCL27) and the CXC family (CXCL3, CXCL5, CXCL7, CXCL8, CXCL16) chemokines. Our results indicate that MoDC largely inherit the chemokines constitutively expressed by monocytes, with a significant induction of CCL17, CCL22 and CCL23. Spent culture supernatant collected from MoDC exhibited chemotatic abilities to activate CD4(+), CD8(+), and CD25(+) Foxp3(+) regulatory T cells (Tregs). Selective knock down of CCL22 and CCL17 expression by siRNA decreased the ratios of CD4(+) to CD8(+), as well as the frequency of Tregs recruited by MoDC. Intratumoural injection of MoDC transfected with siCCL22 and siCCL17, significantly reduced the number of Tregs while increasing the number of infiltrating CD8(+) T cells in human tumour xenografts in athymic nude mice. This study demonstrates that chemokine expression of MoDC is complex and may change dynamically. Using siRNA to selectively knock down chemokines which are highly chemoattractive to Tregs may consequentially alter the lymphocyte populations recruited into the tumour microenvironment, therefore has the potency to provide insight into cellular interactions in cancer immunology. This may lead to a new strategy for DC vaccine development to improve cancer immunobiotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450895     DOI: 10.1016/j.imbio.2009.03.001

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  17 in total

Review 1.  Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

Authors:  V Kumar
Journal:  Purinergic Signal       Date:  2012-12-28       Impact factor: 3.765

2.  Resistance to Immunotherapy: Mechanisms and Means for Overcoming.

Authors:  Mohamad A Salkeni; John Y Shin; James L Gulley
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.

Authors:  Mi Zhou; Paige M Bracci; Lucie S McCoy; George Hsuang; Joseph L Wiemels; Terri Rice; Shichun Zheng; Karl T Kelsey; Margaret R Wrensch; John K Wiencke
Journal:  Int J Cancer       Date:  2015-02-02       Impact factor: 7.316

4.  Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.

Authors:  Sin Mun Tham; Kee Hui Ng; Sim Hwee Pook; Kesavan Esuvaranathan; Ratha Mahendran
Journal:  Clin Dev Immunol       Date:  2011-10-13

5.  Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment.

Authors:  Ying Dai; Zhifeng Wu; Huiming Sheng; Zhengwei Zhang; Mengxi Yu; Qing Zhang
Journal:  Mol Vis       Date:  2015-04-10       Impact factor: 2.367

6.  Different maturation cocktails provide dendritic cells with different chemoattractive properties.

Authors:  Chiara Massa; Carolin Thomas; Ena Wang; Francesco Marincola; Barbara Seliger
Journal:  J Transl Med       Date:  2015-06-03       Impact factor: 5.531

7.  IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent.

Authors:  Fiona C McKay; Edwin Hoe; Grant Parnell; Prudence Gatt; Stephen D Schibeci; Graeme J Stewart; David R Booth
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 8.  Characteristics of tertiary lymphoid structures in primary cancers.

Authors:  Jérémy Goc; Wolf-Herman Fridman; Catherine Sautès-Fridman; Marie-Caroline Dieu-Nosjean
Journal:  Oncoimmunology       Date:  2013-10-22       Impact factor: 8.110

9.  Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma.

Authors:  Yi-Lien Chen; Bor-Luen Chiang
Journal:  Mol Ther Nucleic Acids       Date:  2016-05-03       Impact factor: 10.183

10.  Genomic Programming of Human Neonatal Dendritic Cells in Congenital Systemic and In Vitro Cytomegalovirus Infection Reveal Plastic and Robust Immune Pathway Biology Responses.

Authors:  Widad Dantoft; Pablo Martínez-Vicente; James Jafali; Lara Pérez-Martínez; Kim Martin; Konstantinos Kotzamanis; Marie Craigon; Manfred Auer; Neil T Young; Paul Walsh; Arnaud Marchant; Ana Angulo; Thorsten Forster; Peter Ghazal
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.